AI Summary
This article discusses the use of a targeted gadolinium-based contrast agent for magnetic resonance imaging (MRI) of fibroblast activation protein. The study focuses on the potential of this imaging technique in detecting and monitoring fibroblast activation in various pathological conditions. The findings could lead to improved diagnostic and therapeutic approaches for diseases characterized by fibroblast activation.
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c01250